Early Access — free while we kick the tires
EdgarHawk

ALAM JOHN J

CEO & President

Director Officer 10% Owner
3 filings analyzed · 1 company · Latest 2025-11-19

Companies

Company Buys Sells Direction
CervoMed Inc. CRVO 6 0 Net buying

Activity

November 2025
2025-11-19 CervoMed Inc. CRVO
high
Buy
21,600 shares
$182,736
Significance 6/10

CRVO CEO ALAM bought 21,600 shares at $8.46 in 2 transactions on 2025-11-17 for $182,736.00; stock -39.7% from 52-week high amid cluster buying.

CEO John J Alam purchased 21,600 shares across 2 separate transactions totaling $182,736.00 at $8.46 per share on 2025-11-17, shifting his holdings from a short position (-9,100 shares) to a long position (12,500 shares post-transaction). The purchase occurs while the stock trades -39.7% from its 52-week high of $14.29, following a +14.8% move over 30 days. This buy is part of a cluster pattern with 3 other insiders also purchasing within the past 14 days, though all 4 of Alam's prior same-ticker trades (2025-11-12 through 2025-11-14) remain unmeasurable in outcome. The company posted revenue of $322,569.00 (latest quarter) against net income of $-7,726,639.00 and remains unprofitable on a full-year basis, while annual revenue growth stands at +36.3%. The rapid succession of insider purchases combined with the company's unprofitable state and significant distance from recent highs merits investor attention to both the underlying fundamentals and the pattern of insider accumulation.

2025-11-17 CervoMed Inc. CRVO
high
Buy
7,847 shares
$59,101
Significance 6/10

CEO John J Alam buys 7,847 shares at blended $7.53 ($59.1K); stock +16.0% in 30d, cluster buy pattern with 3 other insiders in past 14 days

John J Alam, CEO & President, executed 3 separate purchases totaling 7,847 shares for $59,101.11 at an average price of $7.53 between November 13–14, 2025. The timing coincides with a broader cluster pattern: 3 other insiders also bought within the past 14 days. The stock has appreciated 16.0% over the prior 30 days and is currently trading at $8.21, representing a 9.0% gain from the blended transaction price. However, the company remains unprofitable with a net income of $-7.7M in the latest quarter, though annual revenue growth stands at +36.3%. Prior trades at this ticker lack measurable 90-day outcomes, limiting confidence in whether this activity reflects durable conviction or routine portfolio activity.

2025-11-13 CervoMed Inc. CRVO
medium
Buy
5,553 shares
$40,815
Significance 5/10

CEO Alam bought 5,553 shares of CRVO at $7.35; stock down 49.3% from 52-week high, cluster of 2 other insider buys in past 14 days.

ALAM JOHN J (CEO & President) purchased 5,553 shares at $7.35 on 2025-11-12, increasing his holdings to 1,467,131 shares. This transaction occurs as CRVO trades at $7.25, down 49.3% from its 52-week high of $14.29 and down 28.4% over the past 90 days, reflecting material recent weakness. Notably, 2 other insiders also bought within the past 14 days, forming a cluster buy pattern. However, the company's fundamentals remain challenged: it reported a net loss of $-7.7M on quarterly revenue of $322.6K, with full-year profitability still negative despite annual revenue growth of 36.3%. The CEO's cross-ticker track record shows only 1 prior open-market buy (outcome not yet measurable), and his same-ticker history at CRVO is similarly limited, providing minimal context for assessing the significance of this purchase amid deteriorated valuation and ongoing losses.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access